MoonLake Immunotherapeutics logo

MoonLake Immunotherapeutics

MLTX | NASDAQ
Chart Builder DCF Calculator
$12.55
+$0.16 (+1.29%)
At close: Sep 21, 2026, 4:00 PM ET
$12.60
+$0.05 (+0.40%)
Pre-market: Sep 22, 2026, 8:21 AM ET
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 845K 751K n/a 742K n/a n/a 32.52K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.49K n/a n/a n/a
Gross Profit
n/a -845K -751K n/a -742K n/a n/a -32.52K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.49K n/a n/a n/a
Operating Income
-61.66M -70.02M -65.22M -71.43M -60.7M -47.49M -49.58M -43.11M -30.58M -19.82M -15.03M -12.98M -13.19M -12.93M -16.7M -14.77M -17.65M -15.94M -14.28M -6.27M -32.68M -94.11K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 17.82K
Pretax Income
-61.72M -69.09M -62.77M -70.58M -55.96M -40.41M -46.35M -36.02M -24.68M -13.91M -7.84M -11.59M -12.34M -12.21M -16.46M -14.73M -17.41M -15.87M -14.31M -6.29M -32.69M -76.29K
Net Income
-61.81M -69.71M -62.43M -69.73M -55.22M -39.94M -45.6M -35.39M -24.27M -13.67M -7.44M -9.43M -10.14M -9M -1.94M -10.11M -12.12M -15.88M -14.32M -6.29M -32.69M -76.29K
Selling & General & Admin
11.44M 15.51M 9.21M 10.8M 10.94M 11.03M 9.22M 7.38M 6.92M 6.81M 6.93M 5.39M 4.48M 5.52M 5.33M 5.75M 6.25M 5.49M 9.28M 5.6M 2.81M 94.11K
Research & Development
50.22M 53.67M 57.49M 60.64M 49.02M 36.46M 40.36M 35.7M 23.66M 13.01M 8.1M 7.59M 8.7M 7.42M 11.37M 9.02M 11.4M 10.45M 4.99M 669.53K 29.87M n/a
Other Expenses
n/a n/a -2.24M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
61.66M 69.18M 64.47M 71.43M 59.96M 47.49M 49.58M 43.08M 30.58M 19.82M 15.03M 12.98M 13.19M 12.93M 16.7M 14.77M 17.65M 15.94M 14.27M 6.27M 32.68M 94.11K
Interest Expense
2.63M 2.27M 2M 3.2M 2.04M 18K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
61.66M 70.02M 65.22M 71.43M 60.7M 47.49M 49.58M 43.11M 30.58M 19.82M 15.03M 12.98M 13.19M 12.93M 16.7M 14.77M 17.65M 15.94M 14.28M 6.27M 32.68M 94.11K
Income Tax Expense
90K 622K 248K 115K 95K 153K 41.14K 92.11K 79K 70K 44.31K 28.92K 10.15K 11.01K 11.01K 8.74K 9.28K 7.33K 4.76K n/a n/a n/a
Shares Outstanding (Basic)
73.92M 71.27M 64.46M 63.37M 63.28M 63.23M 63.07M 62.9M 62.87M 62.64M 59.91M 53.52M 43.72M 39.06M 38.84M 36.93M 35.2M 36.93M 36.93M 36.93M 36.93M 14.81M
Shares Outstanding (Diluted)
73.92M 71.27M 64.46M 63.37M 63.28M 63.23M 63.07M 62.9M 62.87M 62.64M 59.91M 53.52M 43.72M 39.06M 38.84M 36.93M 35.2M 36.93M 36.93M 36.93M 36.93M 14.81M
EPS (Basic)
-0.84 -0.98 -0.93 -1.10 -0.87 -0.63 -0.72 -0.56 -0.39 -0.22 -0.12 -0.18 -0.23 -0.31 -0.05 -0.40 -0.49 -0.43 -0.06 -0.17 -0.89 -0.01
EPS (Diluted)
-0.84 -0.98 -0.93 -1.10 -0.87 -0.63 -0.72 -0.56 -0.39 -0.22 -0.12 -0.18 -0.23 -0.31 -0.05 -0.40 -0.49 -0.43 -0.06 -0.17 -0.89 -0.01
EBITDA
-58.19M -65.97M -60.02M -66.64M -53.18M -40.01M -45.05M -35.99M -24.34M -13.58M -7.84M -11.59M -12.34M -12.2M -16.45M -14.73M -17.4M -15.87M -14.31M -6.29M -32.69M -76.29K
EBIT
-59.08M -66.82M -60.77M -67.38M -53.92M -40.39M -46.35M -36.02M -24.68M -13.91M -7.84M -11.59M -12.34M -12.21M -16.46M -14.73M -17.41M -15.87M -14.31M -6.29M -32.69M -76.29K
Depreciation & Amortization
896K 845K 751K 745K 742K 378K 1.3M 32.52K 342K 328K 3.29K 3.29K 3.29K 3.29K 3.29K 3.29K 3.29K 2.49K 2.49K 2.27K n/a n/a

© 2026 bestshares.com. All rights reserved.